HEALTHEQUITY, INC.
For the period ended Jul 31, 2025. Filed Sep 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2025 · Filed Sep 2, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-04-30; filed 2025-06-03.
0001428336-25-000022
Item 1A. Risk factorsCurrent report: 10-Q
Period ended 2025-07-31; filed 2025-09-02.
0001428336-25-000029
Item 1A. Risk factorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 6 previous paragraphs and 7 current paragraphs.
4 unchanged; 2 reworded; 1 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
(3)In June 2025, our board of directors approved a new stock repurchase program that authorized the repurchase of up to an additional $300 million of our common stock as market conditions warrant.
Reworded paragraphs (2)
Previous wording
(1)Repurchases may be effected through open market purchases, privately negotiated transactions or otherwise, including through Rule 10b5-1 plans. See Note 9—Stockholders' equity for additional information related to our stock repurchase program.
Current wording
(1)Repurchases may be effected through open market purchases, privately negotiated transactions or otherwise, including through Rule 10b5-1 plans. See Note 9—Stockholders' equity for additional information related to our stock repurchase programs.
Previous wording
(2)Average price paid per share includes costs associated with the repurchases.
Current wording
(2)Average price paid per share includes transaction fees but excludes excise tax associated with the repurchases.